Cargando…

Safety Aspects and Rational Use of Testosterone Undecanoate in the Treatment of Testosterone Deficiency: Clinical Insights

Testosterone deficiency is diagnosed by a serum total testosterone level below 300 ng/dL in combination with symptoms such as decreased energy and libido. These symptoms can be ameliorated by restoring serum testosterone to the physiologic range with testosterone therapy (TT). There are numerous for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campbell, Katherine, Muthigi, Akhil, Ghomeshi, Armin, Schuppe, Kyle, Sandler, Max D, Ramasamy, Ranjith
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072151/ https://www.ncbi.nlm.nih.gov/pubmed/37025099 http://dx.doi.org/10.2147/DHPS.S383130

Ejemplares similares

Oral testosterone undecanoate is an effective treatment for micropenis therapy
por: Saenger, Paul, et al.
Publicado: (2021)

Exploring the efficacy of testosterone undecanoate in male children with 5α‐reductase deficiency
por: Liu, Ying, et al.
Publicado: (2021)

A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal Men
por: Swerdloff, Ronald S, et al.
Publicado: (2020)

Comparative application of testosterone undecanoate and/or testosterone propionate in induction of benign prostatic hyperplasia in Wistar rats
por: An, Jinho, et al.
Publicado: (2022)

Strawberry Decreases Intraluminal and Intestinal Wall Hydrolysis of Testosterone Undecanoate
por: Zgair, Atheer, et al.
Publicado: (2021)

Corrigendum for: “A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal Men”
Publicado: (2020)

Importance of measuring testosterone in enzyme-inhibited plasma for oral testosterone undecanoate androgen replacement therapy clinical trials
por: Lachance, Sylvain, et al.
Publicado: (2015)

Anaphylaxis Triggered by Benzyl Benzoate in a Preparation of Depot Testosterone Undecanoate
por: Ong, Gregory S. Y., et al.
Publicado: (2012)

Optimal injection interval for testosterone undecanoate treatment of hypogonadal and transgender men
por: Shankara Narayana, Nandini, et al.
Publicado: (2021)

Misconceptions of Vaping Among Young Adults
por: Golan, Roei, et al.
Publicado: (2023)

Effects of the oral testosterone undecanoate Kyzatrex™ on ambulatory blood pressure in hypogonadal men
por: White, William B., et al.
Publicado: (2021)

Occurrence of Pulmonary Oil Microembolism After Testosterone Undecanoate Injection: A Postmarketing Safety Analysis
por: Pastuszak, Alexander W., et al.
Publicado: (2020)

Seasonal Variation in Serum Testosterone Levels: Evidence from 2 Large Institutional Databases
por: Miller, David, et al.
Publicado: (2023)

Effectiveness of a low dose testosterone undecanoate to improve sexual function in postmenopausal women
por: Tungmunsakulchai, Reuthairat, et al.
Publicado: (2015)

SUN-234 Effect of Testosterone Undecanoate on Metabolic Syndrome Parameters in a Cohort of Hypogonadism
por: Yadav, Subhash Chandra, et al.
Publicado: (2019)

A new oral testosterone undecanoate therapy comes of age for the treatment of hypogonadal men
por: Swerdloff, Ronald S., et al.
Publicado: (2020)

Spectrophotometric and chromatographic strategies for exploring of the nanostructure pharmaceutical formulations which contains testosterone undecanoate
por: Butnariu, Monica, et al.
Publicado: (2020)

Recovery of Male Reproductive Endocrine Function Following Prolonged Injectable Testosterone Undecanoate Treatment
por: Shankara-Narayana, Nandini, et al.
Publicado: (2021)

Safety Analysis of an Oral Testosterone Undecanoate (TU) Formulation Following 2 Years of Administration in Hypogonadal Men
por: Swerdloff, Ronald S, et al.
Publicado: (2021)

Transcriptional Differences in Identical Twins With Different Reproductive Capacities: A Case Report
por: Campbell, Katherine, et al.
Publicado: (2023)

Effects of Low-Dose Testosterone Undecanoate Treatment on Bone Mineral Density and Bone Turnover Markers in Elderly Male Osteoporosis with Low Serum Testosterone
por: Wang, Yan-Jiao, et al.
Publicado: (2013)

Testosterone replacement and prostate cancer
por: Ramasamy, Ranjith, et al.
Publicado: (2012)

Suppression of spermatogenesis by testosterone undecanoate-loaded injectable in situ-forming implants in adult male rats
por: Zhang, Xiao-Wei, et al.
Publicado: (2016)

Pharmacological treatment for pubertal progression in boys with delayed or slow progression of puberty: A small-scale randomized study with testosterone enanthate and testosterone undecanoate treatment
por: Österbrand, Martin, et al.
Publicado: (2023)

Efficacy and safety outcomes of a compounded testosterone pellet versus a branded testosterone pellet in men with testosterone deficiency: a single-center, open-label, randomized trial
por: Kresch, Eliyahu, et al.
Publicado: (2023)

Testosterone Therapy in Men with Klinefelter Syndrome: Analysis of a Global Federated Research Network
por: Carto, Chase, et al.
Publicado: (2022)

Effects of Five-Year Treatment with Testosterone Undecanoate on Metabolic and Hormonal Parameters in Ageing Men with Metabolic Syndrome
por: Francomano, Davide, et al.
Publicado: (2014)

Corrigendum to a new oral testosterone undecanoate (TU) therapy comes of age for the treatment of hypogonadal men
Publicado: (2021)

Population Pharmacokinetic Modeling and Simulations to Evaluate a Potential Dose Regimen of Testosterone Undecanoate in Hypogonadal Males
por: Pastuszak, Alexander W., et al.
Publicado: (2021)

SUN-227 Monitoring Testosterone (T) Levels in Men Receiving Oral Testosterone Undecanoate (TU): Challenges Due to Post-Collection Conversion of TU-to-T and a Path Forward
por: Swerdloff, Ronald, et al.
Publicado: (2019)

Risks of testosterone replacement therapy in men
por: Osterberg, E. Charles, et al.
Publicado: (2014)

Low Testosterone in Adolescents & Young Adults
por: Cohen, Jordan, et al.
Publicado: (2020)

Short-Acting Testosterone: More Physiologic?
por: Westfield, Gerwin, et al.
Publicado: (2020)

Testosterone Therapy in Advanced Prostate Cancer
por: Chedrawe, Emily, et al.
Publicado: (2022)

The putative mechanisms underlying testosterone and cardiovascular risk
por: Maganty, Avinash, et al.
Publicado: (2014)

UGT2B17 Genotype and the Pharmacokinetic Serum Profile of Testosterone during Substitution Therapy with Testosterone Undecanoate. A Retrospective Experience from 207 Men with Hypogonadism
por: Bang, Anne Kirstine, et al.
Publicado: (2013)

Risks of testosterone therapy in elderly men
por: Ramasamy, Ranjith, et al.
Publicado: (2014)

Corrigendum: Low Testosterone in Adolescents & Young Adults
por: Cohen, Jordan, et al.
Publicado: (2020)

PMON267 Comparison Between Single Time Point Testing and 24-Hour Average Concentration of Total Testosterone in Hypogonadal Men Treated with an Oral Testosterone Undecanoate Softgel (JATENZO®)
por: Swerdloff, Ronald, et al.
Publicado: (2022)

Testosterone replacement therapy for physician assistants and nurse practitioners
por: Ramos, Libert, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b5skn7gpi0b318dij31vd5rnhh